Immediate hypersensitivity reactions to anti-SARS-CoV-2 neutralizing
monoclonal antibodies: a real-life experience.
- Alessandro Farsi
, - Laura Franceschini
13 Sep 2022Submitted to Allergy 13 Sep 2022Submission Checks Completed
13 Sep 2022Assigned to Editor
14 Sep 2022Reviewer(s) Assigned
23 Sep 2022Review(s) Completed, Editorial Evaluation Pending
21 Oct 20221st Revision Received
24 Oct 2022Review(s) Completed, Editorial Evaluation Pending
24 Oct 2022Submission Checks Completed
24 Oct 2022Assigned to Editor
25 Oct 2022Reviewer(s) Assigned
07 Nov 2022Editorial Decision: Revise Minor
09 Nov 20222nd Revision Received
09 Nov 2022Assigned to Editor
09 Nov 2022Submission Checks Completed
09 Nov 2022Review(s) Completed, Editorial Evaluation Pending
12 Nov 2022Editorial Decision: Accept
